Expert Interview
A Second Look: Discussing the ongoing HERIZON-GEA-01 trial from Jazz Pharma in 1L Gastroesophageal Adenocarcinoma (GEA) (zanidatamab + chemotherapy ± tislelizumab)
Ticker(s): JAZZ, ZYMEInstitution: Mayo Clinic
- Hematologist/Oncologist at the Mayo Clinic in Jacksonville, FL
- Specializes in gastrointestinal (GI) malignancies and treats 20+ GEA patients yearly
- Clinical research interest and expertise in neuroendocrine tumors, neuroendocrine carcinoma (NEC), colon cancer, esophageal cancer, liver cancer, pancreatic cancer, and stomach cancer; and has co-authored papers and book chapters on these subjects.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
